Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Bristol Myers Squibb (BMYMP) Other Operating Expenses (2016 - 2025)

Bristol Myers Squibb (BMYMP) has disclosed Other Operating Expenses for 17 consecutive years, with $6.3 billion as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses fell 8.41% to $6.3 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.6 billion through Dec 2025, down 41.66% year-over-year, with the annual reading at $21.6 billion for FY2025, 41.66% down from the prior year.
  • Other Operating Expenses for Q4 2025 was $6.3 billion at Bristol Myers Squibb, up from $4.8 billion in the prior quarter.
  • The five-year high for Other Operating Expenses was $18.3 billion in Q1 2024, with the low at $4.4 billion in Q1 2025.
  • Average Other Operating Expenses over 5 years is $6.0 billion, with a median of $5.3 billion recorded in 2021.
  • The sharpest move saw Other Operating Expenses soared 308.54% in 2024, then crashed 76.04% in 2025.
  • Over 5 years, Other Operating Expenses stood at $5.3 billion in 2021, then decreased by 9.21% to $4.8 billion in 2022, then grew by 10.08% to $5.3 billion in 2023, then surged by 30.24% to $6.8 billion in 2024, then dropped by 8.41% to $6.3 billion in 2025.
  • According to Business Quant data, Other Operating Expenses over the past three periods came in at $6.3 billion, $4.8 billion, and $6.2 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.